Matt Gittus
@mattgittus.bsky.social
PhD Fellow at University of Sheffield
THIS institute
Nephrology registrar
Mixed methods researcher
THIS institute
Nephrology registrar
Mixed methods researcher
🚨 New Publication – Systematic Mapping Review on ADPKD Diagnostics
📖 Read it here
The diagnostic accuracy of ultrasound and genomic tests for the diagnosis of autosomal-dominant polycystic kidney disease: a systematic mapping review
#ADPKD #Genomics #DiagnosticAccuracy #Ultrasound #CKJ
📖 Read it here
The diagnostic accuracy of ultrasound and genomic tests for the diagnosis of autosomal-dominant polycystic kidney disease: a systematic mapping review
#ADPKD #Genomics #DiagnosticAccuracy #Ultrasound #CKJ
July 30, 2025 at 2:40 PM
🚨 New Publication – Systematic Mapping Review on ADPKD Diagnostics
📖 Read it here
The diagnostic accuracy of ultrasound and genomic tests for the diagnosis of autosomal-dominant polycystic kidney disease: a systematic mapping review
#ADPKD #Genomics #DiagnosticAccuracy #Ultrasound #CKJ
📖 Read it here
The diagnostic accuracy of ultrasound and genomic tests for the diagnosis of autosomal-dominant polycystic kidney disease: a systematic mapping review
#ADPKD #Genomics #DiagnosticAccuracy #Ultrasound #CKJ
Reposted by Matt Gittus
NEW on the #AJKDBlog:
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
July 19, 2025 at 4:02 PM
NEW on the #AJKDBlog:
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
@maximalchange.bsky.social interviews the authors of a recent review of ADPKD, Sara S. Jdiaa and Reem A. Mustafa, and discusses prognosis, goals, and monitoring.
bit.ly/Jdiaa25 (FREE)
Reposted by Matt Gittus
#Flozins in ADPKD. Interesting VA data suggesting that they may be safe and have a role in renal preservation
journals.lww.com/cjasn/fullte...
journals.lww.com/cjasn/fullte...
July 17, 2025 at 7:09 PM
#Flozins in ADPKD. Interesting VA data suggesting that they may be safe and have a role in renal preservation
journals.lww.com/cjasn/fullte...
journals.lww.com/cjasn/fullte...
Reposted by Matt Gittus
1/ 🧬 Exciting news! Our group just published a paper in Nature Communications on using serum proteomics to predict disease progression in #ADPKD (Autosomal Dominant Polycystic Kidney Disease) 🔬 — enhancing risk stratification beyond currently available models 🎯 rdcu.be/exbNq
Developing serum proteomics based prediction models of disease progression in ADPKD
Nature Communications - Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst formation and loss of kidney function, yet prognostic biomarkers remain limited....
rdcu.be
July 21, 2025 at 4:13 PM
1/ 🧬 Exciting news! Our group just published a paper in Nature Communications on using serum proteomics to predict disease progression in #ADPKD (Autosomal Dominant Polycystic Kidney Disease) 🔬 — enhancing risk stratification beyond currently available models 🎯 rdcu.be/exbNq
📄 Updated UKKA Commentary: Tolvaptan in ADPKD
This work provides clinical context and practical guidance on the use of Tolvaptan for ADPKD, reflecting current evidence, real-world challenges, and expert consensus.
#ADPKD #Tolvaptan #UKKA #RenalMedicine #ClinicalGuidance #KidneyHealth
This work provides clinical context and practical guidance on the use of Tolvaptan for ADPKD, reflecting current evidence, real-world challenges, and expert consensus.
#ADPKD #Tolvaptan #UKKA #RenalMedicine #ClinicalGuidance #KidneyHealth
July 28, 2025 at 10:02 AM
📄 Updated UKKA Commentary: Tolvaptan in ADPKD
This work provides clinical context and practical guidance on the use of Tolvaptan for ADPKD, reflecting current evidence, real-world challenges, and expert consensus.
#ADPKD #Tolvaptan #UKKA #RenalMedicine #ClinicalGuidance #KidneyHealth
This work provides clinical context and practical guidance on the use of Tolvaptan for ADPKD, reflecting current evidence, real-world challenges, and expert consensus.
#ADPKD #Tolvaptan #UKKA #RenalMedicine #ClinicalGuidance #KidneyHealth
📢 New Publication!
I'm pleased to share our latest article in BMC Medicine:
"A conceptual model of factors potentially influencing prescribing decisions for chronic conditions: an overview of systematic reviews."
#Prescribing #ChronicConditions #ImplementationScience #BMCMedicine #THISInstitute
I'm pleased to share our latest article in BMC Medicine:
"A conceptual model of factors potentially influencing prescribing decisions for chronic conditions: an overview of systematic reviews."
#Prescribing #ChronicConditions #ImplementationScience #BMCMedicine #THISInstitute
A conceptual model of factors potentially influencing prescribing decisions for chronic conditions: an overview of systematic reviews - BMC Medicine
Background Nearly half of all adults are affected by chronic conditions with long-term medications often being the primary intervention. Although models like that of Murshid and Mohaidin contribute to...
bmcmedicine.biomedcentral.com
July 28, 2025 at 10:01 AM
📢 New Publication!
I'm pleased to share our latest article in BMC Medicine:
"A conceptual model of factors potentially influencing prescribing decisions for chronic conditions: an overview of systematic reviews."
#Prescribing #ChronicConditions #ImplementationScience #BMCMedicine #THISInstitute
I'm pleased to share our latest article in BMC Medicine:
"A conceptual model of factors potentially influencing prescribing decisions for chronic conditions: an overview of systematic reviews."
#Prescribing #ChronicConditions #ImplementationScience #BMCMedicine #THISInstitute